Background {#Sec1}
==========

The global crisis caused by the coronavirus pandemic 2019 (COVID-19) continues to escalate. According to the World Health Organization (WHO), infections have been confirmed in most countries of the world. As of May 28, the total number of deaths reached over 340,000 (WHO [@CR33], May 28). In order to control COVID-19, most nations have implemented social distancing and self-isolation measures to restrict people from going outside and engaging in social activities. Furthermore, even in places where restrictions are lax, many people have concerns about being infected with COVID-19 (Lin [@CR12]). Until now, the new regulations regarding our lifestyle, including social distancing, self-isolation, and wearing personal protective equipment, have shown to be effective in reducing the number of new COVID-19 infections (Shrivastava and Shrivastava [@CR26]; Siedner et al. [@CR27]); however, all these measures have resulted in dramatic changes in people's everyday lives.

Several studies have sought to explore the effects of these new social practices of social distancing and self-isolation on people's mental suffering, including mental health and other psychological aspects. For instance, Pancani et al. ([@CR19]) found that extended social isolation has worsened people's mental health in Italy. Furthermore, in a series of international surveys, Nelson et al. ([@CR15]) revealed that stringent self-quarantine behavior results in increased depression and anxiety. Likewise, an extensive review of previous research on the psychological impact of past pandemics---such as severe acute respiratory syndrome (SARS), Ebola, and H1N1 influenza---demonstrated that quarantine leads to poorer mental health and increased fear of infection (Brooks et al. [@CR4]). Overall, during disease outbreaks, mental health issues and diseases can emerge or aggravate both directly, by the epidemic itself, and indirectly, i.e., as an effect of disease control measures (Lin and Cheng [@CR13]). In this context, there is an urgent need to explore how the COVID-19 pandemic affects the mental health and psychological well-being of the world's population. However, until now, no such study has been conducted in Japan. Of note, in order to investigate the influence of the COVID-19 pandemic on mental health, one would need to investigate both pandemic-specific mental states and general mental health, such as depression and anxiety. Previous research on past pandemics demonstrated that the fear of infection plays an important role in people's mental health (Pappas et al. [@CR20]) and preventive behaviors (Pakpour and Griffiths [@CR17]). For instance, during the SARS pandemic, the fear of infection was found to be associated with post-traumatic stress symptoms (Ho et al. [@CR8]), suggesting that fear of contracting a virus could lead to stress-related symptoms.

In response to the need of investigating the impact of the COVID-19 pandemic on the world's population, the Fear of COVID-19 Scale (FCV-19S) has been recently developed (Ahorsu et al. [@CR1]). The FCV-19S is a valid and robust psychological assessment scale to evaluate the fear of COVID-19 (Pakpour et al. [@CR18]). While the initial version of the scale was developed in Persian (Ahorsu et al. [@CR1]), the instrument was then translated into several languages, including English (Ahorsu et al. [@CR1]), Italian (Soraci et al. [@CR28]), and Bangla (Sakib et al. [@CR23]). Using the results of the FCV-19S in clinical treatment can contribute to patients' well-being. Used as a screening tool within the general population, the FCV-19S can also help to identify individuals and groups in need of targeted psychological support, such as counseling and psychotherapy.

Adolescents are a potentially vulnerable group in this respect. While the COVID-19 death rate in younger populations has been reported to be lower than among older people (WHO [@CR34], May 29), adolescents suffer from social distancing and self-isolation caused by school closures and other dramatic changes in their environment. Accordingly, many researchers have appealed to the need for a long-term examination of and appropriate psychological care for adolescents in the emerging COVID-19 pandemic (Lee [@CR11]; Viner et al. [@CR31]). This need is reinforced by the evidence that, overall, worsened mental health in adolescents predicts the onset of mental disorders in adulthood (Fogel et al. [@CR5]; Johnson et al. [@CR10]). Indeed, a recent report has revealed that social distancing measures implemented during the COVID-19 pandemic are associated with depression and anxiety in adolescents (Oosterhoff et al. [@CR16]).

Considering the evidence reviewed above and the lack of a Japanese version of the FCV-19S, the present study aims to produce an adapted Japanese version of the FCV-19S instrument and to validate it among the Japanese adolescent population. The adaptation of the Japanese version of the scale undertaken in this research is based on the original FCV-19S (Ahorsu et al. [@CR1]) and its translated versions (Sakib et al. [@CR23]; Satici et al. [@CR24]; Soraci et al. [@CR28]). The results of the present study contribute to the available literature on the association between the COVID-19 pandemic and mental health in Japan, as well as facilitate prospective global comparative research on mental health, including the fear of COVID-19.

Method {#Sec2}
======

Participants {#Sec3}
------------

The data collection was performed in mid-May 2020 in two junior high schools in Japan. The survey was conducted in cooperation with the board of education and school principals of the two schools. The survey took place during designated classes in the two schools. Upon obtaining informed consent from all participants and the explanations of the teachers in charge of those classes, the students filled in the questionnaire. A total of 629 adolescents (309 females; mean age = 12.96, SD = 0.83) participated in this study. All procedures involved in this study were approved by the ethics committee of Iryo Sosei University (\#20-02), the chairman of the board of education, and the school principals.

FCV-19S Scale Translation {#Sec4}
-------------------------

The English version of the FCV-19S (Ahorsu et al. [@CR1]) was translated into Japanese following the guidelines of the International Society for Pharmacoeconomics and Outcomes Research Task Force (Wild et al. [@CR32]). First, two psychologists independently translated the seven items of the FCV-19S from English to Japanese. Second, these two translations were integrated into one and back-translated into English by another English/Japanese speaker without prior knowledge of the FCV-19S. The process of back-translation confirmed the equivalence between the original version (Ahorsu et al. [@CR1]) and the Japanese translation. The Japanese FCV-19S was then piloted among several adolescent individuals. After minor modifications suggested by the pilot pretest, the final version of the Japanese FCV-19S was produced.

Measures {#Sec5}
--------

### Fear of COVID-19 Scale {#Sec6}

The Japanese-version Fear of COVID-19 Scale (FCV-19S) was used to measure the participants' fear in relation to the COVID-19 infection ([Appendix](#Sec15){ref-type="sec"}). This unifactor instrument consisted of seven items to be rated on a 5-point scale (1 = "strongly disagree"; 5 = "strongly agree"). Therefore, the total score ranged from 7 to 35, with a higher score indicating a greater fear of COVID-19. The satisfactory internal consistency and validation of the scale were confirmed in the original version of the scale (*α* = .82; Ahorsu et al. [@CR1]).

### Generalized Anxiety Disorder 7-Item Scale {#Sec7}

The Japanese version of the Generalized Anxiety Disorder (GAD-7; Spitzer et al. [@CR29]), validated by Muramatsu et al. ([@CR14]), was used to measure the participants' anxiety symptoms. The unifactor GAD-7 consists of seven items to be rated on a 4-point scale (1 = "not at all"; 4 = "nearly every day"). The total score ranged from 0 to 21, with higher values indicating more severe anxiety. The internal consistency of the scale was excellent (*α* = .92; Muramatsu et al. [@CR14]).

### Patient Health Questionnaire for Adolescents {#Sec8}

The Japanese version of the Patient Health Questionnaire for Adolescents (PHQ-A; Johnson et al. [@CR9]) was used to measure the participants' depressive symptoms. The PHQ-A consists of nine items to be rated on a 4-point scale ranging from 1 = "not at all" to 4 = "nearly every day." The total score ranged from 0 to 27, with higher scores indicating stronger depressive symptoms.

### Perceived Vulnerability to Disease Scale {#Sec9}

The Japanese-version Perceived Vulnerability to Disease Scale (PVDS) was used to measure the participants' perceived vulnerability to disease and infection. The PVDS consists of 15 items and has a two-factor structure: perceived infectability (seven items) and germ aversion (eight items). The participants responded to each item on a 7-point scale ranging from 1 = "strongly disagree" to 7 = "strongly agree." The total scores ranged from 7 to 49 (perceived infectability) and 8 to 56 (germ aversion), with higher scores indicating greater perceived vulnerability. This scale was previously reported to have acceptable internal consistency (*α* = .87, .67, and .79; perceived infectability, germ aversion, and total score respectively; Fukukawa et al. [@CR6]).

Data Analyses {#Sec10}
-------------

To verify the structural validity of the Japanese version of the FCV-19S, a confirmatory factor analysis (CFA) with the diagonally weighted least squares (DWLS) estimation was performed. The following indices of model fit were considered: comparative fit index (CFI), root mean square error of approximation (RMSEA), and standardized root mean square residual (SRMR). Following Schermelleh-Engel et al. ([@CR25]), an acceptable fit criterion was regarded as CFI \> .95, RMSEA \< .08, and SRMR \< .10; a good fit criterion was regarded as a CFI \> .97, RMSEA \< .05, and SRMR \< .05.

The reliability of the Japanese version of the FCV-19S was evaluated using Cronbach's alpha. To examine construct validity, we calculated Pearson's correlation coefficients with the comparison measures (i.e., the score of the GAD-7, PHQ-A, and PVDS). The strength of the correlation was determined following Andresen ([@CR3]) where *r* \< .30 was "weak," *r* = .30--.59 was "moderate," and *r* ≥ .60 was "strong." The participants with missing values were excluded from all analyses. Statistical analyses were performed using IBM SPSS Statistics 25 and R ver. 4.0.1 with the lavaan package (Rosseel [@CR22]).

Results {#Sec11}
=======

Descriptive statistics of the Japanese-version FCV-19S---including mean, standardized deviation, skewness, kurtosis, and floor/ceiling effects---are summarized in Table [1](#Tab1){ref-type="table"}. The skewness and kurtosis values in all items ranged from − 2 to + 2, except for the kurtosis value in item 6. For items 3, 6, and 7, over 65% of the respondents reported the lowest scores, indicating a possibility of the floor effect. However, overall Cronbach's alpha was .82 (see below for further discussion). These results suggested that the Japanese-version of the FCV-19S has a good detectability regarding change and variance of fear of COVID-19.Table 1Descriptive statistics of the Japanese version of the FCV-19SFCV-19S*N*Mean*SD*SkewnessKurtosisFloor (%)Ceiling (%)Item 16294.041.19− 1.350.947.4744.99Item 26273.391.37− 0.50− 0.9814.8324.72Item 36271.610.981.551.5865.871.59Item 46283.891.32− 1.04− 0.1110.3544.43Item 56292.811.35− 0.01−1.3024.6410.33Item 66271.460.851.903.0671.610.80Item 76291.540.961.701.8970.911.11Emotional response62614.144.29− 0.71− 0.314.316.23Physiological response6264.612.231.562.2650.640.32Total score62318.715.65− 0.13− 0.304.330.32

The results of the CFA to verify the structural validity of the Japanese version of the FCV-19S are summarized in Table [2](#Tab2){ref-type="table"}. The indices showed that the bi-factor model was the best fit for our data (CFI = .997, RMSEA = .034, SRMR = .040), compared with the single-factor model (CFI = .952, RMSEA = .103, SRMR = .106) and the two-factor model (CFI = .983, RMSEA = .064, SRMR = .064). Therefore, we adopted the bi-factor model as an integrated model with an original general factor (Ahorsu et al. [@CR1]) and two-factor model consisting of the "emotional response" factor (items 1, 2, 4, and 5) and "physiological response" factor (items 3, 6, and 7). In this decision, we followed a previous study by Reznik et al. ([@CR21]) using the Russian version of the FCV-19S in Russia and Belarus. Indeed, our results are consistent with those reported by Reznik et al. ([@CR21]) in that the estimates were .561 or higher, suggesting a robust construction of each factor. The statistics for each factor are summarized in Table [1](#Tab1){ref-type="table"}. Furthermore, Cronbach's alphas of the Japanese-version FCV-19S were .82 in total, .71 in emotional response, and .82 in physiological response, suggesting that both factors had sufficiently high reliability.Table 2Model comparisons of the FCV-19S based on confirmatory analysesModel*χ*^2^*dfp* valueCFIRMSEASRMRSingle-factor model106.52614\< .001.952.103.106Two-factor model46.12913\< .001.983.064.060Bi-factor model13.7738.088.997.034.040

To test the construct validity of the Japanese-version FCV-19S, a correlation analysis was performed on each variable (Table [3](#Tab3){ref-type="table"}). The results showed that the correlation coefficients between each factor of the Japanese-version FCV-19S and each of the factors in the PVDS ranged from .16 to .25 (*p* \< .001), suggesting that both the emotional and physiological fear responses towards COVID-19 were related to the perception of one's vulnerability to disease. Furthermore, the results of correlation analysis showed that depressive symptoms significantly correlated with physiological response (*r* = .19), while anxiety symptoms significantly correlated with emotional response (*r* = .11), physiological response (*r* = .25), and overall fear of COVID-19 (*r* = .18; all *p* values \< .001). Taken together, these results indicate that the Japanese-version FCV-19S has a moderately good construct validity to measure the fear of COVID-19. Overall, compared with Ahorsu et al. ([@CR1]), we obtained relatively lower correlation coefficients between the fear of COVID-19 and each variable. This inconsistency of correlation coefficients with other versions of the FCV-19S instrument (Ahorsu et al. [@CR1]; Sakib et al. [@CR23]; Soraci et al. [@CR28]) could be attributed to the influence of the biases in distribution that were observed in the PHQ-A (skewness = 1.55, kurtosis = 3.02) and GAD-7 (skewness = 2.18, kurtosis = 6.22).Table 3Correlations between the FCV-19S and comparison variablesFCV-19SEmotionalPhysiologicalTotal scoreFCV-19S  Emotional response1.00  Physiological response.45\*\*\*1.00  Total score.94\*\*\*.74\*\*\*1.00PVDS  Perceived infectability.16\*\*\*.20\*\*\*.20\*\*\*  Germ aversion.19\*\*\*.25\*\*\*.24\*\*\*  Total score.12\*\*.20\*\*\*.17\*\*\*PHQ-A.00.19\*\*\*.08GAD-7.11\*\*.25\*\*\*.18\*\*\*\**p* \< .05, \*\**p* \< .01, \*\*\**p* \< .001

In summary, despite several floor effects in the data, the results demonstrated that the Japanese version of the FCV-19S has a bi-factor model: emotional response (items 1, 2, 4, and 5), physiological response (items 3, 6, and 7), and general factor (overall), with a sufficiently high internal confidence and a moderately good construct validity.

Discussion {#Sec12}
==========

The present study aimed to produce a Japanese version of the FCV-19S and validate it among Japanese adolescents. The results of statistical analyses revealed that the Japanese version of the FCV-19S has a bi-factor model; high internal consistency in the emotional response factor, physiological response factor, and general factor; and a moderately good construct validity. Based on these results, it can be concluded that the Japanese version of the FCV-19S is a valid instrument to measure the fear of COVID-19 among Japanese adolescents.

The results of the CFA showed that the bi-factor model was the best fit for our data. This result is not in line with the findings reported in previous studies using other versions of the scale, such as Persian (Ahorsu et al. [@CR1]), Bangla (Sakib et al. [@CR23]), Italian (Soraci et al. [@CR28]), Turkish (Satici et al. [@CR24]), and Arabic (Alyami et al. [@CR2]); all these studies found that the unifactor model was the best fit. However, our results are consistent with Reznik et al.'s ([@CR21]) study that administered the Russian version of the FCV-19S in Russia and Belarus. Furthermore, according to Alyami et al. ([@CR2]), the factor loads of items 3, 6, and 7---which were assigned to the physiological response factor in the present study and in Reznik et al. ([@CR21])---had lower mean values than the remaining items. Therefore, taking into account the symptoms described in items 3, 6, and 7 (clammy hands, sleep disturbance, and palpitation due to COVID-19), it can be concluded that fear-related somatic symptoms would be less experienced by the participants, as somatic symptoms were specific to a severe state of fear of COVID-19.

The results of correlation analysis performed to confirm construct validity revealed that emotional response in the FCV-19S significantly correlated with physiological response (*r* = .45) and total score (*r* = .94) in the FCV-19S, perceived infectability (*r* = .16), germ aversion (*r* = .19), and anxiety (*r* = .11) and that physiological response significantly correlated with perceived infectability (*r* = .20), germ aversion (*r* = .25), depression (*r* = .19), and anxiety (*r* = .25). These results suggest that the emotional and physiological aspects of the fear of COVID-19 measured by the Japanese version of the FCV-19S are related to mental health and the perception of one's vulnerability to the disease. Although the significance and direction of the correlations in our results were largely consistent with those obtained using the original version and other translated versions of the FCV-19S, correlation coefficients in our results were lower than those found in previous studies. This outcome can be attributed to the following two reasons. First, while we administered the FCV-19S among adolescents, other studies used the scale to survey adult populations. Accordingly, divergences between our and previous studies could be related to qualitative differences in the underlying association between the fear of COVID-19 and mental health in adolescents vs. adults. Second, the aforementioned divergence could be attributed to the fact that, compared with most European countries, Japan has been less affected by COVID-19 (i.e., fewer infections and cases of death). Accordingly, the pandemic could have had a weaker impact on mental health in Japan. Overall, despite the somewhat lower values, our results demonstrated that the Japanese version of the FCV-19S has moderately good construct validity.

The contribution of the present study is twofold. First, to the best of our knowledge, our study is the first to apply the FCV-19S to adolescents. Despite the relatively lower health risks associated with COVID-19 in this population, adolescents are nevertheless psychologically vulnerable to the negative effects of the measures implemented to curb the pandemic, such as school closures, enhancing social distancing, and online learning. This brings about the need to investigate how quarantine strategies affect adolescents' mental health (Golberstein et al. [@CR7]; Viner et al. [@CR31]; WHO [@CR34], May 29), as well as to elaborate appropriate strategies, such as school-based psychoeducation and/or group psychotherapy, that would help adolescents cope with psychological issues caused by the pandemic.

Second, the present study is the first to produce and validate the Japanese version of the FCV-19S. This version complements those already available in other languages---such as Persian (original version; Ahorsu et al. [@CR1]), English (Ahorsu et al. [@CR1]), Bangla (Sakib et al. [@CR23]), Italian (Soraci et al. [@CR28]), Turkish (Satici et al. [@CR24]), Arabic (Alyami et al. [@CR2]), and Greek (Tsipropoulou et al. [@CR30])---and facilitates prospective global comparative research on mental health, including the fear of COVID-19.

Limitations {#Sec13}
===========

The present study has several limitations. Firstly, as mentioned in the "[Results](#Sec11){ref-type="sec"}" section, floor effects were found in the PHQ-A and GAD-7. This might be the result of underachieving construct validity in the Japanese version of the FCV-19S. Further research that would measure mental health by a wide range in the Japanese healthy adolescent population would be needed. Secondly, our data sample was limited to students of two junior high schools located in one prefecture with a relatively low total number of confirmed COVID-19 cases (specifically, 81 cases as of May 28). Therefore, it is possible that the participants of the present study were less concerned about COVID-19 compared with comparable adolescent cohorts from European countries or from other areas in Japan that have been more affected by the coronavirus. Finally, in the present study, we did not explore the possibility that school closures and online learning could have improved the participants' mental health through the elimination of many school-driven stressors, such as bullying, interacting with others, upcoming tests, and class participation. Therefore, in future studies, it would be necessary to investigate the psychological effects of school closures from the perspective of educational psychology.

Conclusion {#Sec14}
==========

The present study adapted and validated the Japanese version of the Fear of COVID-19 Scale (FCV-19S) in a sample of Japanese adolescents. Factor analysis of the participants' responses yielded a bi-factor model, with one dimension being the emotional response and the other dimension the physiological response. This model was found to have a high internal consistency (emotional: *α* = .71; physiological: *α* = .82) and moderately good construct validity. Further research on the impact of COVID-19 pandemic on the mental health of both the general population and adolescents is needed.

Appendix. The Japanese-version Fear of COVID-19 Scale (新型コロナウイルス恐怖尺度) {#Sec15}
==================================================================================
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